Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19.
Destras G, Assaad S, Bal A, Bouscambert-Duchamp M, Avrillon V, Simon B, Valette M, Blay JY, Lina B, Frobert E, Josset L.
Destras G, et al. Among authors: simon b.
Lancet Microbe. 2021 Sep;2(9):e424. doi: 10.1016/S2666-5247(21)00189-0. Epub 2021 Jul 28.
Lancet Microbe. 2021.
PMID: 34341781
Free PMC article.
No abstract available.